NEWS

ten23 health’s expansion in Visp will be operational by en 2024 !

Swiss CDMO ten23 health has announced in its press release that its large-scale pre-filled syringe, cartridge and vial aseptic filling line 2 (VIVA2) in Visp (Switzerland) will be GMP operational by end 2024! Located near by our Visp technological site of BioArk, the ten23 Health’s expansion, previously first announced in June, 2022 is  now completing …

ten23 health’s expansion in Visp will be operational by en 2024 ! Read More »

ImmunSkills transforms cell therapy for cancer treatment

As head of start-up ImmunSkills, based at our BioArk Monthey technology site, Adolfo Gonzalez has propelled the company to notable achievements in the field of cell-based therapy. Through our interview with its CEO, discover how ImmunSkills is transforming cancer treatment by introducing revolutionary methods and therapeutic advances designed to offer more accessible and effective treatments …

ImmunSkills transforms cell therapy for cancer treatment Read More »

Scroll to Top